Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Immunohistochemical HER2 Status Evaluation In Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study

NCT02580799 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT02580799
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02580799 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Immunohistochemical HER2 Status Evaluation In Breast Cancer Pathology Samples: A Multicenter, Parallel-Design Concordance Study
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
February 28, 2014
Completion date
October 31, 2014
Enrollment
30 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer